| Literature DB >> 20490294 |
Abstract
Natural resources in general and plant materials in particular are receiving more attention due to their safety as pharmaceutical excipients. Present work assessed the potential of a natural polysaccharide, pectin to mask the bitter taste of ambroxol hydrochloride, by microencapsulation technique, and its possibility to formulate as a fast disintegrating dosage form. Taste masking is an important developmental challenge in fast dissolving drug delivery system since it dissolves or disintegrates in the patient's mouth in close proximity to the taste buds. The prepared microspheres by emulsion solvent evaporation technique possessed good sphericity, smooth surface morphology, uniform and narrow size distribution (10-90 mum), when analyzed by scanning electron microscopy, laser diffraction and optical microscopy. Method of preparation has influenced the particle size and drug loading efficiency. Drug-polymer compatibility was confirmed by Fourier transform infrared spectroscopy and thin layer chromatography. DSC and X-ray diffraction studies revealed that the drug was dispersed inside the microspheres in the form of an insoluble matrix. The formation of microspheres was affected by glass transition temperature of the polymer, surfactant, type of plasticizers, volume of internal phase, stirrer speed etc. Fast dissolving tablets were prepared by the modification of melt granulation technique. The resulting granules were found to melt fast at body temperature, have smooth mouth feel and good physical stability. This study demonstrated that pectin could be a right choice in developing patient favored formulations for bitter drugs and can be utilized in fast disintegrating dosage forms as well.Entities:
Keywords: Aqueous colloidal polymer dispersion; microencapsulation; microsphere pectin; taste masking
Year: 2009 PMID: 20490294 PMCID: PMC2865786 DOI: 10.4103/0250-474X.56028
Source DB: PubMed Journal: Indian J Pharm Sci ISSN: 0250-474X Impact factor: 0.975
Fig. 1Scanning electron micrograph of microspheres.
Scanning electron micrograph of a single and group of pectin microspheres, drug:pectin ratio is 1:7.
Fig. 2DSC Thermograms of drug microspheres and physical mixtures.
DSC Thermograms of A. ambroxol, B. pectin, C. drug microspheres and D. physical mixtures
EFFECT OF POLYMER RATIO ON THE AMBROXOL HCL LOADING OF PECTIN MICROSPHERES*
| Drug:Polymer | Theoretical drug loading (%) | Actual loading (%) | Encapsulation efficiency (%) |
|---|---|---|---|
| 1:1 | 50.0 | 38.38±5.78 | 76.76±4.67 |
| 1:2 | 33.33 | 26.59±7.89 | 79.77±3.67 |
| 1:4 | 20.0 | 17.87±4.83 | 89.35±3.78 |
| 1:7 | 12.5 | 11.90±3.26 | 95.20±3.98 |
| 1:10 | 9.09 | 6.09±7.90 | 66.99±5.41 |
Each value is the means of n=3 determinations
FORMULATION OF A FAST MELTS TABLET PREPARED BY DIRECT COMPRESSION
| Ingredients | mg/tablet |
|---|---|
| Ambroxol hydrochloride microparticles (equivalent to 30 mg ambroxol HCl) | 240.56 |
| Croscarmellose sodium | 25.0 |
| Corn starch | 30.0 |
| Aspartame sodium | 9.5 |
| Americant mint | 3.5 |
| Silicon dioxide | 3.0 |
| Magnesium stearate | 2.1 |
| Fast dissolving granulation | 186.34 |
| Total | 500.0 |
Fig. 3Dissolution profile of ambroxol from conventional tablet and selected microencapsulated fast melt tablet. Dissolution profile of ambroxol from conventional tablets (–▲–) and selected microencapsulated fast melt tablet (–*–) (B4) in 0.1N HCl. Each value is a mean±SD of 3 determinations
EFFECT OF THE VOLUME OF THE INTERNAL PHASE ON THE AMBROXOL HCL LOADING AND PARTICLE SIZE OF PECTIN MICROSPHERES (DRUG: PECTIN 1:7)
| Internal phase (ml) | Theoretical drug loading (%) | Actual drug loading(%) | Encapsulation efficiency(%) | Mean Particle size (μm±SD) |
|---|---|---|---|---|
| 2 | 12.5 | 11.67 | 93.36±1.13 | 10.7±0.98 |
| 4 | 12.5 | 12.01 | 96.08±0.11 | 22.37±0.08 |
| 8 | 12.5 | 10.72 | 85.76±0.35 | 80.88±0.97 |
| 15 | 12.5 | 9.98 | 79.84±0.49 | 90.83±0.79 |
EFFECT OF THE VOLUME OF THE INTERNAL PHASE ON THE PARTICLE SIZE OF PECTIN MICROSPHERES (DRUG: PECTIN 1:7).
| Internal phase (ml) | Specific surface area (m2/g) | Surface weighted mean D[3,2] | Volume weighted mean D[4,3] | Mean particle size, d(0.5) (μm±SD) |
|---|---|---|---|---|
| 2 | 0.604 | 9.93 | 40.46±0.32 | 37.26±0.89 |
| 4 | 0.238 | 25.16 | 103.31±0.43 | 70.05±0.45 |
| 8 | 0.218 | 27.56 | 150.14±0.67 | 93.82±0.97 |
| 15 | 0.053 | 112.19 | 302.19±0.75 | 172.5±0.79 |
EFFECT OF THE TEMPERATURE OF OIL PHASE ON AMBROXOL HCL LOADING IN TO PECTIN MICROSPHERES
| Temperature (°C) | Theoretical drug loading(%) | Actual drug loading (%) | Encapsulation efficiency (%) |
|---|---|---|---|
| 60 | 12.5 | 11.98±0.11 | 95.84±0.45 |
| 70 | 12.5 | 12.04±0.40 | 96.32±0.78 |
| 80 | 12.5 | 11.95±0.61 | 95.60±0.67 |
Effect of the temperature of liquid paraffin oil phase on ambroxol HCl loading in to pectin microspheres with a 1:7 ration of drug to pectin
FORMULATION AND HARDNESS, DISINTEGRATION TIME AND DISSOLUTION CHARACTERISTICS OF BATCHES IN A 32 FULL FACTORIAL DESIGN
| Batch No. | Variable level in coded form | Hardness of tablets (kg/cm2) | Disintegration Time (sec) | t80 (min) | |
|---|---|---|---|---|---|
| X1 | X2 | Y1 | Y2 | Y3 | |
| B1 | −1 | −1 | 3 | 65 | 30 |
| B2 | −1 | 0 | 3 | 52 | 28 |
| B3 | −1 | 1 | 3 | 60 | 35 |
| B4 | 0 | −1 | 3.5 | 30 | 24 |
| B5 | 0 | 0 | 3 | 45 | 34 |
| B6 | 0 | 1 | 3.5 | 46 | 40 |
| B7 | 1 | −1 | 2 | 29 | 29 |
| B8 | 1 | 0 | 2 | 50 | 30 |
| B9 | 1 | 1 | 2 | 54 | 32 |
All batches contained 500 g of polyethylene glycol 1000. Coded values of −1, 0, and 1 stand for, X1 ratio of 0:2000 and X2 ratio of 20:2000, X1 ratio of 1000:1000 and X2 ratio of 40:1500 and X1 ratio of 2000:0 and X2 ratio of 60:1000, respectively. X1 is the ratio of xylitol to dextrose and X2 is the ratio of colloidal silicon dioxide to microcrystalline cellulose.
CHARACTERISTICS OF PREPARED TABLETS
| Properties | B1 | B2 | B3 | B4 | B5 | B6 | B7 | B8 | B9 |
|---|---|---|---|---|---|---|---|---|---|
| Angle of repose (θ) | 25.86 | 26.94 | 26.54 | 29.76 | 28.74 | 29.94 | 27.54 | 25.67 | 26.23 |
| 0.623 | 0.321 | 0.124 | 0.398 | 0.231 | 0.114 | 0.342 | 0.162 | 0.215 | |
| Compressibility (%) | 24.67 | 26.76 | 27.32 | 29.32 | 28.88 | 29.43 | 26.54 | 25.52 | 27.65 |
| 0.456 | 0.327 | 0.226 | 0.438 | 0.198 | 0.217 | 0.179 | 0.146 | 0.210 | |
| Friability (%) | 0.765 | 0.789 | 0.801 | 0.567 | 0.623 | 0.774 | 0.745 | 0.732 | 0.724 |
| 0.119 | 0.123 | 0.131 | 0.113 | 0.114 | 0.124 | 0.126 | 0.126 | 0.127 | |
| Porosity (%) | 11.32 | 12.13 | 12.18 | 11.98 | 11.76 | 11.95 | 12.01 | 12.31 | 12.43 |
| 0.011 | 0.012 | 0.014 | 0.011 | 0.014 | 0.015 | 0.015 | 0.016 | 0.016 | |
| Wetting time (sec) | 77.0 | 58.0 | 65.0 | 43.0 | 52.0 | 50.0 | 41.0 | 58.0 | 57.0 |
| 4.56 | 3.89 | 2.76 | 3.98 | 4.56 | 4.12 | 3.32 | 3.14 | 3.56 | |
| Water absorption ratio (sec) | 77.56 | 86.96 | 79.93 | 92.12 | 89.97 | 90.12 | 93.48 | 87.71 | 88.98 |
| 4.67 | 5.32 | 6.76 | 4.32 | 5.68 | 7.76 | 3.34 | 4.67 | 4.36 | |
| 67.0 | 55.0 | 58.0 | 32.0 | 48.0 | 50.0 | 37.0 | 58.0 | 58.0 | |
| 4.43 | 3.98 | 4.12 | 3.27 | 5.12 | 2.67 | 3.33 | 4.12 | 4.76 | |
| % Ambroxol absorbed from buccal cavity. | 18.12 | 17.58 | 17.77 | 18.43 | 16.76 | 17.34 | 17.01 | 15.55 | 15.02 |
| 1.68 | 1.23 | 1.59 | 1.98 | 1.69 | 1.46 | 1.76 | 2.01 | 2.79 |
Physical characteristics such as friability, porosity, wetting time, water absorption ratio and in vivo disintegration time and percentage absorption of drug of prepared tablets. Each value is the mean with CV